| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |